We innovate and develop products that improve patients’ quality of life.
DSM stands for Degradable Starch Microspheres, a patented technology based on fully biodegradable, biocompatible particles derived from natural materials, designed to deliver innovative medical solutions.
DSM degrade to glucose in the human body
DSM are derived from potato starch
DSM are spherical particles on the microscale (1 – 1000 micrometers in diameter)
DSM technology transforms starch-based microspheres into highly adaptable delivery systems that can be tailored to different medical challenges. By combining different formulations with various active ingredients, DSM can be used to address currently unmet medical needs, providing patients and healthcare professional with effective and innovative treatment options.
This flexible approach enables us to:
Whether used on their own or in combination with potent substances, DSM formulations create value for patients, providers, and the healthcare system.
Because DSM are so adaptable, a range of formulations can be created, enabling diverse applications. Each DSM formulation is designed for different delivery methods and therapeutic effects:
At Magle PharmaCept, we are dedicated to advancing patient care through a strong evidence-based approach. Clinical research is at the core of our commitment to ensuring the safety and effectiveness of our products. With over 25 years of experience in product development and realization, we continue to invest in meaningful clinical data and outcomes research.
Our track record includes a large number of publications covering both preclinical and clinical studies, reflecting our focus on scientific integrity and innovation. This growing body of evidence supports the real-world value of our technologies and helps guide their responsible use in clinical practice.
Our DSM products are high-quality, clinically tested materials designed for use in a wide range of medical applications.
SmartPAN® helps surgeons instantly detect pancreatic leakage during surgery, supporting secure closure and reducing complications.
EmboCept® S DSM 50 µm offers effective, temporary vessel occlusion for intra-arterial treatment of inoperable liver and lung tumors, used with cytostatic agents.
Our wound care products are developed to support the natural healing process by maintaining a moist wound environment and protecting against external contamination.